Literature DB >> 17054433

Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese.

Keitaro Matsuo1, Hidemi Ito, Yasushi Yatabe, Akio Hiraki, Kaoru Hirose, Kenji Wakai, Takayuki Kosaka, Takeshi Suzuki, Kazuo Tajima, Tetsuya Mitsudomi.   

Abstract

The present study aimed to assess the impact of smoking and sex for the risk of non-small-cell lung cancer (NSCLC) with or without epidermal growth factor receptor (EGFR) mutation. We conducted a case-control study using 152 patients with EGFR-mutated (EGFRmut) NSCLC, 283 with EGFR-wild-type (EGFRwt) NSCLC and 2175 age- and sex-frequency-matched controls. Smoking was a significant risk factor for EGFRwt NSCLC (odds ratio [OR] for ever-smokers, 4.05; 95% confidence interval [CI], 2.79-5.88) but not for EGFRmut NSCLC (OR, 0.73; CI, 0.46-1.14). Sex did not affect this association. The association was observed consistently with other smoking-related parameters including pack-years. Sex was the sole risk factor for EGFRmut NSCLC (OR for women relative to men, 2.19; CI, 1.41-3.39) and there was no significant interaction between women and smoking. In contrast, sex, smoking and their interaction were significant in EGFRwt NSCLC. The impact of sex on EGFR mutation status was assessed by several indicators of reproductive history among women. Total fertile years showed a significant positive association with EGFRmut NSCLC but not with EGFRwt NSCLC. Other indicators showed similar trends and this result may partly explain the sexual difference in the acquisition of EGFR mutation. In conclusion, our case-control study clearly demonstrated that the impacts of smoking and sex on the risk of EGFRmut NSCLC are different from those for EGFRwt NSCLC. Further epidemiological evaluation is warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17054433     DOI: 10.1111/j.1349-7006.2006.00347.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  35 in total

1.  Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.

Authors:  Yang Zhang; Yihua Sun; Yunjian Pan; Chenguang Li; Lei Shen; Yuan Li; Xiaoyang Luo; Ting Ye; Rui Wang; Haichuan Hu; Hang Li; Lei Wang; William Pao; Haiquan Chen
Journal:  Clin Cancer Res       Date:  2012-02-08       Impact factor: 12.531

2.  Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib.

Authors:  Gary M Clark
Journal:  Mol Oncol       Date:  2007-12-08       Impact factor: 6.603

3.  Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium.

Authors:  Soumaya Ben Khedher; Monica Neri; Alexandra Papadopoulos; David C Christiani; Nancy Diao; Curtis C Harris; Susan Olivo-Marston; Ann G Schwartz; Michele Cote; Anita Koushik; Jack Siemiatycki; Maria Teresa Landi; Rayjean J Hung; John McLaughlin; Eric J Duell; Angeline S Andrew; Irene Orlow; Bernard J Park; Hermann Brenner; Kai-Uwe Saum; Angela C Pesatori; Isabelle Stücker
Journal:  Int J Cancer       Date:  2017-05-10       Impact factor: 7.396

4.  The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.

Authors:  Yoon Ki Cha; Ho Yun Lee; Myung-Ju Ahn; Keunchil Park; Jin Seok Ahn; Jong-Mu Sun; Yoon-La Choi; Kyung Soo Lee
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 5.  Lung cancer in women.

Authors:  Raúl Barrera-Rodriguez; Jorge Morales-Fuentes
Journal:  Lung Cancer (Auckl)       Date:  2012-12-15

6.  Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations.

Authors:  Elizabeth M Gaughan; Sarah K Cryer; Beow Y Yeap; David M Jackman; Daniel B Costa
Journal:  Lung Cancer       Date:  2012-12-27       Impact factor: 5.705

7.  Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Authors:  Kenichi Suda; Kenji Tomizawa; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  Int J Clin Oncol       Date:  2011-06-08       Impact factor: 3.402

8.  Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.

Authors:  Conor E Steuer; Madhusmita Behera; Lynne Berry; Sungjin Kim; Michael Rossi; Gabriel Sica; Taofeek K Owonikoko; Bruce E Johnson; Mark G Kris; Paul A Bunn; Fadlo R Khuri; Edward B Garon; Suresh S Ramalingam
Journal:  Cancer       Date:  2015-12-22       Impact factor: 6.860

9.  Genetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer.

Authors:  Carmen J Marsit; E Andres Houseman; Heather H Nelson; Karl T Kelsey
Journal:  J Cancer Epidemiol       Date:  2009-01-28

10.  Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.

Authors:  Daphne W Bell; Brian W Brannigan; Keitaro Matsuo; Dianne M Finkelstein; Raffaella Sordella; Jeff Settleman; Tetsuya Mitsudomi; Daniel A Haber
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.